Literature DB >> 11834663

Role of biochemical tests in the diagnosis of large pericardial effusions.

Lesley J Burgess1, Helmuth Reuter, J J Frans Taljaard, Anton F Doubell.   

Abstract

STUDY
OBJECTIVES: To determine the biochemical characteristics of large pericardial effusions in various disease states, and to assess their utility as diagnostic tools.
SETTING: An academic university hospital in the Western Cape, South Africa.
DESIGN: Consecutive, prospective case series. PATIENTS: One hundred ten hospital patients > 12 years old, who presented to the echocardiography department with large pericardial effusions, and 12 control subjects who underwent open-heart surgery (coronary artery bypass graft or aortic valve replacement). MEASUREMENTS: Fluid was sent for examination of biochemistry, adenosine deaminase, microbiology, hematology, and cytology. The etiology of each pericardial fluid sample was established using predetermined criteria.
RESULTS: The biochemistry of pericardial exudates differed significantly from pericardial transudates. Light' s criteria (whereby an exudate is defined as having one or more of the following: pleural fluid/serum protein ratio > 0.5; pleural fluid/serum lactate dehydrogenase [LDH] ratio > 0.6; and/or pleural fluid LDH level > 200 U/L) were applied to pericardial fluids and demonstrated to be the most reliable diagnostic tool for identifying pericardial exudates. The corresponding sensitivity was 98%.
CONCLUSION: Although laboratory tests are a useful guideline when assessing the etiology and pathophysiology of pericardial effusions, the majority of large, clinically significant pericardial effusions result from exudative causes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11834663     DOI: 10.1378/chest.121.2.495

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  78-year-old man with metastatic squamous cell carcinoma, dyspnea, and hypotension.

Authors:  John P Bois; Alfred G Valles; Lawrence J Sinak
Journal:  Mayo Clin Proc       Date:  2010-11       Impact factor: 7.616

2.  Late ventriculo-atrial shunt migration leading to pericardial cerebrospinal fluid effusion and cardiac tamponade.

Authors:  Ciro Mastroianni; Dorion Chauvet; Olivier Ressencourt; Matthias Kirsch
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-12-11

3.  [Differentiation of malignant from nonmalignant, inflammatory pericardial effusions with biomarkers].

Authors:  Konstantinos Karatolios; Peter Alter; Bernhard Maisch
Journal:  Herz       Date:  2009-12       Impact factor: 1.443

4.  Diagnostic value of biochemical biomarkers in malignant and non-malignant pericardial effusion.

Authors:  Konstantinos Karatolios; Sabine Pankuweit; Bernhard Maisch
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

Review 5.  The common and distinct target genes of the p53 family transcription factors.

Authors:  K Harms; S Nozell; X Chen
Journal:  Cell Mol Life Sci       Date:  2004-04       Impact factor: 9.261

6.  Analysis of C-reactive protein and biochemical parameters in pericardial fluid.

Authors:  Turan Ege; Melih Hulusi Us; Mustafa Cikirikcioglu; Cavidan Arar; Enver Duran
Journal:  Yonsei Med J       Date:  2006-06-30       Impact factor: 2.759

Review 7.  Physiology of pericardial fluid production and drainage.

Authors:  Konstantinos Vogiatzidis; Sotirios G Zarogiannis; Isaac Aidonidis; Evgeniy I Solenov; Paschalis-Adam Molyvdas; Konstantinos I Gourgoulianis; Chrissi Hatzoglou
Journal:  Front Physiol       Date:  2015-03-18       Impact factor: 4.566

8.  A Case of Congenital Lymphedema Complicated by Chronic Chylous Effusions and Recurrent Pericardial Effusion Requiring Pericardial Window.

Authors:  Abdulrahman Katabi; Mohammed Al-Ourani; Fuad Zeid
Journal:  Cureus       Date:  2020-05-16

Review 9.  Pleural, peritoneal and pericardial effusions - a biochemical approach.

Authors:  Lara Milevoj Kopcinovic; Jelena Culej
Journal:  Biochem Med (Zagreb)       Date:  2014-02-15       Impact factor: 2.313

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.